My watch list  


News Tenofovir

  • Remote-controlled implantable device delivers HIV prevention drug

    A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure. The National Institute of Allergy and Infectious Diseases (NIAID) awarded Alessandro Grattoni, Ph.D. more

  • AHF files federal lawsuit against Gilead to invalidate patents on key AIDS drug

    AIDS Healthcare Foundation (AHF) filed a federal lawsuit today against Gilead Sciences Inc. seeking to invalidate patents on key AIDS drugs held by the Bay Area drug maker. The legal action was filed today in U.S. District Court, Northern District of California, and concerns Tenofovir, a key HIV/AID more

  • Agenix Files Key Patent Application for China Hepatitis drug

    Agenix said it had filed an international method of manufacture patent application under the Patent Cooperation Treaty (PCT) for its hepatitis B drug AGX-1009. The application covers the manufacturing process of a compound that uses the same active ingredient, Tenofovir, used in the US Food & Drug A more

All news on tenofovir

Publications Tenofovir

All publications on tenofovir


Tenofovir Tenofovir disoproxil fumarate (TDF or PMPA Tenofovir has also been implicated in causing renal toxicity, particularly at elevated concentrations. HIV risk reduction A 2006 trial by Family Health International gave either Viread or ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE